Results 241 to 250 of about 221,113 (351)

Equity Dashboards in a Statewide Surgical Quality Collaborative: A Mixed Methods Pre‐Implementation Study

Learning Health Systems, EarlyView.
ABSTRACT Introduction Collaborative quality initiatives have leveraged performance dashboards and cross‐institutional learning to improve surgical outcomes. However, these models for quality improvement have yet to integrate tools for improving health disparities.
Erin E. Isenberg, Natalie M. Guzman, Sarah E. Bradley, Michael J. Englesbe, Pasithorn A. Suwanabol, Calista M. Harbaugh   +5 more
wiley   +1 more source

Unveiling GDF15 as a promising biomarker for predicting survival in pancreatic ductal carcinoma: a retrospective research. [PDF]

BMC Cancer
Xiao J, Lu X, Luo W, Wang Y, Zhang T.
europepmc   +1 more source

Ductal carcinoma in situ with infiltrating ductal carcinoma

, 2013
openaire   +1 more source

Stromal collagen IV expression and risk of breast cancer death in ductal carcinoma in situ. [PDF]

BJC Rep
Rask G, Jansson M, Svensson J, Wiberg R, Wärnberg F, Billing O, Wadsten C, Sund M.   +7 more
europepmc   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

Mass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik, Petr Lapcik, Pavla Bouchalova, Pavel Bouchal   +3 more
wiley   +1 more source

Spatiotemporal microenvironment landscape and malignant epithelial pattern transition in breast ductal carcinoma progression. [PDF]

J Transl Med
Cheng X, Zeng W, Yin B, Gui J, Zhang H, Lv Z, Zhang S, Zhou Y.   +7 more
europepmc   +1 more source

Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy

Medicine Bulletin, EarlyView.
ABSTRACT Recently, immune checkpoint inhibitors (ICIs), particularly PD‐1/PD‐L1 and CTLA‐4 inhibitors, have revolutionized cancer treatment, significantly improving survival rates for various malignancies. However, ICI therapies targeting single checkpoints on T cells still face numerous challenges, such as low response rates and post‐treatment ...
Yangyang Li, Zizhen Kang, Yanyun Du
wiley   +1 more source

Does concomitant ductal carcinoma in situ influence the prognostic outcome after neoadjuvant therapy in triple-negative invasive ductal carcinoma? [PDF]

World J Surg Oncol
Zhou S, Liang L, Huang Z, Teng Y, Xing W.   +4 more
europepmc   +1 more source

Circular RNAs: Epigenetic Puppeteers Pulling the Strings of Cancer Pathogenesis

Medicine Bulletin, EarlyView.
ABSTRACT Circular RNAs (circRNAs), a unique class of endogenous noncoding RNAs characterized by their covalently closed loop structure, have emerged as pivotal players in cancer biology due to their exceptional stability, tissue‐specific expression, and diverse regulatory functions.
Yimao Wu, Zichang Chen, Junying Lee, Gokhan Zengin, Meng‐Yao Li   +4 more
wiley   +1 more source

Advances and Prospects of Stereotactic Radiosurgery and Stereotactic Ablative Body Radiotherapy: Evolving Paradigms in Precision Oncology

Med Research, EarlyView.
The graphical abstract outlines the progressive development and impact of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). Technological Evolution illustrates the transition from brachytherapy with single‐dose, LDR/HDR schedules to fractionated radiotherapy, three‐dimensional conformal radiotherapy (3DCRT) and Gamma Knife ...
Jing Zhang, Wenhao Xu, Weiqing Lu, Yingxuan Lin, Luoxi He, Zonglin Lv, Yiliyaer Nuerrula, Zouting, Zhen Zhang, Hailiang Zhang, Xuejun Ma   +10 more
wiley   +1 more source